Chordia Therapeutics Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Chordia Therapeutics Inc. made a loss over the last year. Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns. Chordia Therapeutics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Aug 2025.
P/E ratio
LossChordia Therapeutics Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.61The share price is 1.61 times Chordia Therapeutics Inc.'s book value per share, higher than 53% of Healthcare companies in Japan.
Market cap
¥3.8 BThe total market value of all of Chordia Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥2.3 BWhat Chordia Therapeutics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).
Book value per share
¥31.02Net worth divided by the number of shares. The share price of ¥50.00 is 1.6 times this, which is the P/B above.
Return on equity (ROE)
-66.7%Chordia Therapeutics Inc. lost 66.7% of its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.
Owes vs Owns
0.10×Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns (low), lower than 93% of Healthcare companies in Japan.
Dividend yield
NoneChordia Therapeutics Inc. does not currently pay a dividend.
Profit growth
LossChordia Therapeutics Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Chordia Therapeutics Inc.: ¥3.8 B ÷ ¥2.3 B (31 May 2026) = 1.6.
What is Chordia Therapeutics Inc.'s return on equity?
Chordia Therapeutics Inc. lost 66.7% of its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.
How much does Chordia Therapeutics Inc. owe compared with what it owns?
Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns (low), lower than 93% of Healthcare companies in Japan.
Does Chordia Therapeutics Inc. pay a dividend?
No. Chordia Therapeutics Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.